Tepezza’s Dual Nature: Balancing Therapeutic Efficacy With Unforeseen Risks
Tepezza, the first prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat thyroid eye disease, has garnered significant attention for its … Read more
